Does a novel mutagenic process target KMT2D mutation in the most common first event on the path to bladder cancer

Simon Charles Baker; Andrew Stephen Mason; Jennifer Southgate

doi:10.1016/j.eururo.2020.11.008

Does a novel mutagenic process target KMT2D mutation in the most common first event on the path to bladder cancer

Simon Charles Baker, Andrew Stephen Mason, Jennifer Southgate

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	435-436
Number of pages	2
Journal	European Urology
Volume	79
Issue number	3
Early online date	11 Feb 2021
DOIs	https://doi.org/10.1016/j.eururo.2020.11.008
Publication status	Published - 1 Mar 2021

Bibliographical note

This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy.

Access to Document

10.1016/j.eururo.2020.11.008

Baker Research Letter 271020
This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy.
Accepted author manuscript, 38.8 KBLicence: CC BY-NC-ND

YAC 5 year renewal
Southgate, J.
YORK AGAINST CANCER
1/10/19 → 31/08/26
Project: Research project (funded) › Research

Cite this

@article{b84b9db34be7472688413fbbeb3783d2,

title = "Does a novel mutagenic process target KMT2D mutation in the most common first event on the path to bladder cancer",

author = "Baker, {Simon Charles} and Mason, {Andrew Stephen} and Jennifer Southgate",

note = "This is an author-produced version of the published paper. Uploaded in accordance with the publisher{\textquoteright}s self-archiving policy. ",

year = "2021",

month = mar,

day = "1",

doi = "10.1016/j.eururo.2020.11.008",

language = "English",

volume = "79",

pages = "435--436",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Does a novel mutagenic process target KMT2D mutation in the most common first event on the path to bladder cancer

AU - Baker, Simon Charles

AU - Mason, Andrew Stephen

AU - Southgate, Jennifer

N1 - This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy.

PY - 2021/3/1

Y1 - 2021/3/1

U2 - 10.1016/j.eururo.2020.11.008

DO - 10.1016/j.eururo.2020.11.008

M3 - Article

SN - 0302-2838

VL - 79

SP - 435

EP - 436

JO - European Urology

JF - European Urology

IS - 3

ER -

Does a novel mutagenic process target KMT2D mutation in the most common first event on the path to bladder cancer

Bibliographical note

Access to Document

Projects

YAC 5 year renewal

Cite this